Advertorial, B. “Advertorial: EMA REAFFIRMS POSITIVE BENEFIT-RISK BALANCE OF BAYER’S XARELTO® FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION”. SA Heart Journal, vol. 13, no. 1, Mar. 2017, pp. 42-43, doi:10.24170/13-1-1694.